U.S. flag

An official website of the United States government

NM_000371.4(TTR):c.95T>C (p.Leu32Pro) AND Amyloidosis, hereditary systemic 1

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Jun 23, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000014399.29

Allele description [Variation Report for NM_000371.4(TTR):c.95T>C (p.Leu32Pro)]

NM_000371.4(TTR):c.95T>C (p.Leu32Pro)

Gene:
TTR:transthyretin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
18q12.1
Genomic location:
Preferred name:
NM_000371.4(TTR):c.95T>C (p.Leu32Pro)
Other names:
L12P
HGVS:
  • NC_000018.10:g.31592921T>C
  • NG_009490.1:g.6155T>C
  • NM_000371.4:c.95T>CMANE SELECT
  • NP_000362.1:p.Leu32Pro
  • LRG_416:g.6155T>C
  • NC_000018.9:g.29172884T>C
  • P02766:p.Leu32Pro
Protein change:
L32P; LEU12PRO
Links:
UniProtKB: P02766#VAR_038959; OMIM: 176300.0041; dbSNP: rs121918094
NCBI 1000 Genomes Browser:
rs121918094
Molecular consequence:
  • NM_000371.4:c.95T>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Amyloidosis, hereditary systemic 1 (AMYLD1)
Synonyms:
Amyloidosis Transthyretin related; Amyloid polyneuropathy transthyretin related; Transthyretin amyloidosis; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0971004; MedGen: C2751492; Orphanet: 85447; Orphanet: 85451; OMIM: 105210

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000034648OMIM
no assertion criteria provided
Pathogenic
(Feb 1, 1999)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

SCV004297823Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Jun 23, 2023)
germlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

The biological and chemical basis for tissue-selective amyloid disease.

Sekijima Y, Wiseman RL, Matteson J, Hammarström P, Miller SR, Sawkar AR, Balch WE, Kelly JW.

Cell. 2005 Apr 8;121(1):73-85.

PubMed [citation]
PMID:
15820680

Transthyretin Leu12Pro is associated with systemic, neuropathic and leptomeningeal amyloidosis.

Brett M, Persey MR, Reilly MM, Revesz T, Booth DR, Booth SE, Hawkins PN, Pepys MB, Morgan-Hughes JA.

Brain. 1999 Feb;122 ( Pt 2):183-90.

PubMed [citation]
PMID:
10071047
See all PubMed Citations (4)

Details of each submission

From OMIM, SCV000034648.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

Brett et al. (1999) described the case of a middle-aged woman with a leu12-to-pro (L12P) mutation of the TTR gene product, an extensive amyloid deposition in the leptomeninges and liver as well as the involvement of the heart and peripheral nervous system, typical of familial amyloid polyneuropathy caused by variant TTR (AMYLD1; 105210). Clinical features attributed to her leptomeningeal amyloid included radiculopathy, central hypoventilation, recurrent subarachnoid hemorrhage, depression, seizures, and periods of decreased consciousness. MRI showed a marked enhancement throughout her meninges and ependyma, and TTR amyloid deposition was confirmed by meningeal biopsy. The simultaneous presence of extensive visceral amyloid and clinically significant deposits affecting both peripheral and central nervous system extended the spectrum of amyloid-related disease associated with TTR mutations. Brett et al. (1999) suggested that leptomeningeal amyloidosis should be considered part of the syndrome of TTR-related familial amyloid polyneuropathy. Their index case was 38 years old when she first began to notice easy bruising. Five years later she began to get persistent headaches, and 6 months later presented with severe headache of sudden onset. CT and lumbar puncture confirmed subarachnoid blood, but angiograms showed no definite bleeding point. Two months later she had another subarachnoid bleed. About 4 years later, she started to notice hearing loss bilaterally, increasingly severe headaches, unsteadiness, urinary frequency, incomplete bladder emptying, and poor urinary stream. A CT scan showed hydrocephalus; insertion of a right lateral ventriculoperitoneal shunt was complicated by a small subdural hematoma. After the shunt, her unsteadiness and urinary symptoms partially improved. After a complicated and distressing course the patient died at the age of 53 years. The family history showed that the mother had committed suicide at the age of 62 after 2 years of depression and physical illness that included urinary symptoms, constipation, and falls. However, histologic study of sections of heart, lung, and kidney from the mother's postmortem material showed no amyloid.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004297823.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (4)

Description

For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects TTR function (PMID: 15820680). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt TTR protein function. ClinVar contains an entry for this variant (Variation ID: 13457). This variant is also known as Leu12Pro. This missense change has been observed in individual(s) with TTR-related conditions (PMID: 10071047, 20209591). This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 32 of the TTR protein (p.Leu32Pro).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024